![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blta0f8a1de73f78e8b/658aea22eb36d0040abccbbd/ma-designer491.jpg?disable=upscale&width=1200&height=630&fit=crop)
MolMed latest add-on for expansion hungry AGC Biologics
AGC Biologics has acquired Molecular Medicine (MolMed), increasing its presence in the CDMO space and adding a pipeline of cell and gene therapy candidates. In March, contract development and manufacturing organization (CDMO) AGC Biologics launched a …